HPTN 073 is a demonstration study designed to see if Black men who have sex with men (BMSM) are willing to use Truvada®, a daily pill for pre-exposure prophylaxis (PrEP). HPTN 073 will gather feedback about the experience from the men who elect to use PrEP. PrEP is a new HIV prevention method in which people who are HIV-negative take an HIV treatment drug (antiretroviral – ARV) daily to reduce their risk of becoming HIV-infected.
How Does Trauma-Informed Care Improve Outcomes for Youth With HIV?
PrEP Use Doesn’t Increase STIs Among Black MSM, New Study Shows
Transgender Engagement, Prevention & Care
HIV Partner Service Delivery Among Blacks or African Americans
Webinar: Whole-Health Assessment
Transgender Healthcare Supplemental Reading
Webinar: Transgender Healthcare
4 Phases of Social Network Strategy (SNS) for HIV Testing
Daily Pill Can Prevent HIV Infographics
PODCAST: GET YOURSELF A GAY FRIEND
LGBT Statistics: Having one gay friend makes you a better person
New York City HIV Status Neutral Prevention and Treatment Cycle
We need to talk about ‘top privilege’